World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
40544
World Ranking
8849
National Ranking
493

Danilo Fliser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Danilo Fliser sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 473 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Danilo Fliser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Danilo Fliser sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Danilo Fliser is affiliated with Saarland University in Germany and has a significant body of research centered on medicine, with an emphasis on nephrology, cardiovascular medicine, and related fields. Their work spans subfields including nephrology, surgery, cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, and pulmonary and respiratory medicine.

The main topics covered in their research include:

  • Chronic Kidney Disease and Diabetes
  • Dialysis and Renal Disease Management
  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management
  • Blood Pressure and Hypertension Studies
  • Electrolyte and hormonal disorders
  • Potassium and Related Disorders

Frequent publication venues where Danilo Fliser has contributed include:

  • Nephrology Dialysis Transplantation
  • European Heart Journal
  • Kidney International Reports
  • Journal of the American Society of Nephrology
  • Clinical Kidney Journal

Among recent publications are:

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
  • Cardiovascular Disease in Chronic Kidney Disease, 2021, Circulation
  • Chronic kidney disease and the global public health agenda: an international consensus, 2024, Nature Reviews Nephrology
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Journal of Preventive Cardiology
  • WNT-β-catenin signalling - a versatile player in kidney injury and repair, 2020, Nature Reviews Nephrology

Danilo Fliser has collaborated extensively with several coauthors throughout their career, including:

  • Thimoteus Speer
  • Ziad A. Massy
  • Stefan Schunk
  • Alberto Ortíz
  • Christoph Wanner

Best Publications

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

    Joachim Jankowski;Jürgen Floege;Danilo Fliser;Michael Böhm

  • Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

    Danilo Fliser;Barbara Kollerits;Ulrich Neyer;Donna P. Ankerst

  • Erythropoietin regulates endothelial progenitor cells.

    Ferdinand H. Bahlmann;Kirsten de Groot;Jens-Michael Spandau;Aimee L. Landry

  • A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy

    Danilo Fliser;Maurice Laville;Adrian Covic

  • SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset

    Adam M. Zawada;Kyrill S. Rogacev;Björn Rotter;Peter Winter

  • Simvastatin Versus Ezetimibe Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans

    Ulf Landmesser;Ferdinand Bahlmann;Maja Mueller;Stephan Spiekermann

  • Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer

  • CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.

    Kyrill S. Rogacev;Bodo Cremers;Adam M. Zawada;Sarah Seiler

  • Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

    Danilo Fliser;Konrad Buchholz;Hermann Haller

  • Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

    Jan T. Kielstein;Burcu Impraim;Solveig Simmel;Stefanie M. Bode-Böger

  • Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

    Danilo Fliser;Eberhard Ritz

  • Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

    Jan T. Kielstein;Rainer H. Böger;Stefanie M. Bode-Böger;Jürgen C. Frölich

  • Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    Alberto Ortiz;Adrian Covic;Danilo Fliser;Denis Fouque

  • Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

    Sajoscha A. Sorrentino;Ferdinand H. Bahlmann;Christian Besler;Maja Müller

  • Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study

    Danilo Fliser;Florian Kronenberg;Jan T. Kielstein;Christian Morath

  • Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study

    Bjoern Becker;Florian Kronenberg;Jan T Kielstein;Hermann Haller

  • INSULIN RESISTANCE AND HYPERINSULINEMIA ARE ALREADY PRESENT IN PATIENTS WITH INCIPIENT RENAL DISEASE

    Danilo Fliser;Giovanni Pacini;Giovanni Pacini;Renate Engelleiter;Renate Engelleiter;Alexandra Kautzky-Willer;Alexandra Kautzky-Willer

  • Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

    Jan T. Kielstein;Shelley R. Salpeter;Stefanie M. Bode-Boeger;John P. Cooke

  • Prometheus--a new extracorporeal system for the treatment of liver failure.

    Kinan Rifai;Thomas Ernst;Ulrich Kretschmer;Matthias J Bahr

Frequent Co-Authors

Hermann Haller
Hermann Haller Hannover Medical School
Jan T. Kielstein
Jan T. Kielstein Hannover Medical School
Ziad A. Massy
Ziad A. Massy Versailles Saint-Quentin-en-Yvelines University
Winfried März
Winfried März Medical University of Graz
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid
Adrian Covic
Adrian Covic Grigore T. Popa University of Medicine and Pharmacy
Gérard M. London
Gérard M. London Grenoble Alpes University
Raymond Vanholder
Raymond Vanholder Ghent University
Francesca Mallamaci
Francesca Mallamaci National Research Council (CNR)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open up flexible and rewarding career opportunities, especially for those seeking alternative pathways to medical professions in the USA. If you’re a registered nurse looking to advance your credentials without the demands of in-person training, consider pursuing an rn to bsn without clinicals program. These options let you earn your degree fully online, saving time and fitting into busy schedules.

For those aiming higher, a Doctor of Nursing Practice (DNP) can be achieved efficiently with the shortest dnp program online or by choosing among leading dnp online programs. These programs blend academic rigor with streamlined formats, making advanced leadership roles within nursing more accessible.

Entry-level healthcare roles can also be reached quickly. Aspiring practical nurses may benefit from a 6 month lpn program online, allowing for a fast track into the workforce. No matter your goals, online degrees offer flexible ways to progress in healthcare while balancing other commitments.

Best Scientists Citing Danilo Fliser

Trending Scientists

Recently Published Articles